David K. Song, MD, PhD, CFA

David K. Song, MD, PhD, CFA

David Song, Investment Partner, has led biotechnology and healthcare investment teams throughout his extensive 25-year career at Rockefeller Capital Management, Millennium and Balyasny. He studied Economics and Biochemistry at Yale, is a medical doctor and has a PhD in Applied Economics from Wharton.
Find me on:

Recent Posts

Immuno-oncology’s Second Act

Keytruda (Pembrolizumab) is the world’s biggest drug by sales, on track for more that $24bn in sales in 20231. The drug targets programmed cell death...

Radiopharmaceuticals: Transforming Cancer Care

Radiopharmaceuticals, or radioligand therapies, stand at the forefront of cancer treatment innovation. These therapies employ radioactive compounds...

Pursuing A Better Way To Invest In Life Sciences

We believe life sciences are an important allocation in any portfolio. Yet despite its historical outperformance of the broader market1, executing an...

Neuroscience and Mental Health: the most unmet need in life sciences

By many measures, neurological disorders remain the final frontier of life science research. Recent breakthroughs offer hope that we are at a turning...

Cell therapies - Revolutionizing Cancer Treatment

In oncology, cell therapy is a groundbreaking approach that involves using engineered immune cells, often sourced from the patient, as a "living...

The Next Generation of Cardiovascular Drugs

The cardiometabolic space is more than just the obesity revolution. Although GLP-1 weight loss drugs, like Wegovy, could modify cardiovascular...

Liquid Biopsies - Revolutionizing Cancer Diagnosis

Liquid biopsies, a cutting-edge diagnostic tool, are changing the landscape of cancer detection. They harness bodily fluids, such as blood, to...

Investing in the diabesity epidemic: a breakthrough moment

Cardiovascular and metabolic diseases are a vast chronic burden on patients and society and the leading cause of death globally[1]. However, recent...

Investor's Guide to the Oncology Revolution Webinar Replay

Watch our latest webinar to learn about the exciting investment opportunities and challenges within the rapidly evolving field of cancer therapeutics...

Investing in oncology: a biotech revolution in research, diagnosis, and treatment of cancer

Cancer will affect one in every two people in their lifetime. Yet, oncology is on the brink of a revolution, which we expect will trigger a material...

No results found